Repligen Corporation ($RGEN) Stock Forecast: Up 9.7% Today

What is Repligen Corporation?

Repligen (RGEN) is a company listed on NASDAQ that specializes in providing bioprocessing technology solutions for the biopharmaceutical industry.

Why is Repligen Corporation going up?

RGEN stock is up 9.7% on Feb 20, 2025 19:36

• Repligen (RGEN) reported strong Q4 earnings, surpassing both EPS and revenue expectations, demonstrating solid financial performance.
• The company provided a strong sales forecast for 2025, displaying confidence in its future growth opportunities.
• The favorable earnings results and positive outlook probably boosted investor confidence, causing a bullish trend in RGEN stock.

RGEN Price Chart

RGEN Technical Analysis

RGEN News

Repligen Q4 Earnings Momentum Highlights Market Growth, Issues Strong 2025 Outlook - Repligen ( NASDAQ:RGEN )

Repligen Q4 EPS of $0.44 beat the $0.41 estimate, while revenue of $167.55 million was in line with forecasts. 2025 sales guidance set at $685 million-$710 million vs. $694.9 million consensus, with organic growth of 9.5%-13.5%.

https://www.benzinga.com/25/02/43861240/repligens-q4-earnings-beat-2025-guidance-highlights-market-growth

Repligen ( RGEN ) Beats Q4 Earnings Estimates

Repligen (RGEN) delivered earnings and revenue surprises of 7.32% and 0.10%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

https://www.zacks.com/stock/news/2418411/repligen-rgen-beats-q4-earnings-estimates

Trending Today

Jito ($JTO) Crypto Forecast: Up 19.4% Today

Hims & Hers Health Inc. ($HIMS) Stock Forecast: Down 19.7% Today

Avis Budget Group Inc. ($CAR) Stock Forecast: Down 5.3% Today

Sonic (prev. FTM) ($S) Crypto Forecast: Up 10.6% Today

Alibaba Group Holding Limited ($BABA) Stock Forecast: Up 5.0% Today

Algorand ($ALGO) Crypto Forecast: Up 5.7% Today

Dollar Tree Inc. ($DLTR) Stock Forecast: Up 5.0% Today

Pinduoduo Inc. ($PDD) Stock Forecast: Up 5.1% Today

Movement ($MOVE) Crypto Forecast: Up 6.9% Today

Copart Inc. ($CPRT) Stock Forecast: Down 5.2% Today

Repligen Corporation Price History

26.08.2024 - RGEN Stock was up 5.9%

• Repligen announced the grand opening of its Repligen Training & Innovation Center (RTIC) at its Waltham headquarters, showcasing a commitment to enhancing customer experience and innovation.
• The move to support biopharma and CDMO customer experience with the company's bioprocessing technologies likely generated positive investor sentiment, leading to the bullish movement in RGEN stock.
• The focus on training and innovation could signal potential growth opportunities and increased competitiveness in the bioprocessing technology sector, driving optimism among investors and contributing to the stock's upward momentum.

03.08.2024 - RGEN Stock was down 5.2%

• Following the latest earnings disclosure, Repligen's stock experienced a 13.1% drop.
• Concerns around the company's future earnings prospects may have fueled the bearish movement.
• The absence of positive forecasts or updates on forthcoming initiatives might have impacted RGEN's stock performance adversely.
• Market participants appear to be awaiting clearer indications of a possible recovery before contemplating investments in Repligen.

14.10.2024 - RGEN Stock was down 5.3%

• Repligen (RGEN) reported strong Q3 earnings and revenue beats, showcasing a robust financial performance.
• Despite the positive earnings report, the stock experienced a bearish movement, possibly due to the company lowering its guidance for 2024 total sales.
• Investors might be reacting to the mixed guidance provided by Repligen, causing a sell-off in the stock despite the positive earnings surprises.
• The market movement could also be influenced by profit-taking activities following the stock's recent strong performance, as investors reassess their positions based on the new sales outlook provided by the company.

23.09.2024 - RGEN Stock was down 5.5%

• The negative market movement could be linked to concerns about Repligen's upcoming Q3 earnings release, amid worries of potential underperformance.
• Investors possibly reacted to perceived limited growth opportunities in the earnings report, resulting in a sell-off of RGEN shares.
• Uncertainty surrounding the company's ability to meet earnings projections may have influenced the downward trend in stock price today.

20.01.2025 - RGEN Stock was up 9.7%

• Repligen (RGEN) reported strong Q4 earnings, surpassing both EPS and revenue expectations, demonstrating solid financial performance.
• The company provided a strong sales forecast for 2025, displaying confidence in its future growth opportunities.
• The favorable earnings results and positive outlook probably boosted investor confidence, causing a bullish trend in RGEN stock.

20.01.2025 - RGEN Stock was up 11.0%

• Repligen (RGEN) beat Q4 earnings estimates, showing a strong performance in the last quarter.
• The positive earnings surprise of 7.32% and revenue beat of 0.10% likely contributed to the bullish movement in the stock.
• Investors may be optimistic about the company's future prospects based on these strong financial results.
• The market reaction indicates that investors are confident in Repligen's ability to continue its growth trajectory in the bioprocessing sector.

12.10.2024 - RGEN Stock was up 7.7%

• Repligen (RGEN) reported Q3 earnings and revenues that surpassed analysts' estimates, indicating strong financial performance.
• The better-than-expected results suggest that the company's bioprocessing technologies are in high demand, potentially leading to increased market share and profitability.
• Investors may be reacting positively to the earnings beat, driving the bullish movement in RGEN's stock price today.
• The outperformance in earnings and revenues could signal continued growth and success for Repligen, attracting more investors to the stock.

12.10.2024 - RGEN Stock was up 6.2%

• Repligen (RGEN) saw a notable upward trend today subsequent to its Q3 earnings announcement.
• The company's reported adjusted EPS and sales exceeded expectations, showcasing robust financial performance and growth potential.
• Analysts express optimism regarding Repligen's future growth prospects, attributing this to enhanced market conditions and the company's strong competitive position.
• The favorable earnings and revenue outcomes likely bolstered investor confidence in Repligen, propelling the stock price upwards.

18.11.2024 - RGEN Stock was down 5.1%

• The bearish movement in RGEN's stock could be due to profit-taking by investors after a recent 3.2% increase since the last earnings report.
• The publication of the company's 2023 Corporate Sustainability Report may not have had the desired positive impact on the stock price, leading to a sell-off.
• Investors might be cautious about the future outlook of the company, as reflected in the bearish market movement despite the recent earnings report.

29.00.2025 - RGEN Stock was down 5.2%

• Previous rise in Repligen's shares may have resulted in an overestimation of the stock's value, prompting investors to sell off.
• The notable trading volume, combined with the absence of additional positive earnings forecasts, likely influenced profit-taking and a subsequent bearish trend.
• Investors possibly viewed the recent price uptick as unsustainable, triggering a sell-off and contributing to a bearish market trend for Repligen (RGEN) today.

16.00.2025 - RGEN Stock was up 5.2%

• Positive comparisons with other stocks in the same sector, indicating potential undervaluation and attracting investors.
• Increased investor confidence in the company's value proposition and growth prospects, leading to higher demand for the stock.
• Market optimism towards the biotechnology sector as a whole, driving up prices of related stocks like RGEN.

12.01.2025 - RGEN Stock was down 5.0%

• The upcoming financial results announcement may have led to uncertainty and profit-taking among investors, causing a bearish sentiment.
• Investors might be concerned about the company's performance in the fourth quarter of 2024, leading to a sell-off of shares.
• The market may be reacting to potential guidance or outlook provided by Repligen Corporation during the conference call, impacting the stock negatively.
• Traders could be adjusting their positions based on expectations or rumors circulating about the financial health of Repligen Corporation, contributing to the bearish movement in the stock price.